Skip to content

A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00168415
Enrollment
144
Registered
2005-09-15
Start date
2005-08-31
Completion date
2007-06-30
Last updated
2008-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperhidrosis

Brief summary

A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.

Interventions

BIOLOGICALBotulinum Toxin Type A

100 U up to 6 times during the study depending on the response to treatment

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Marked axillary hyperhidrosis

Exclusion criteria

* Previous use of botulinum toxin for hyperhidrosis

Design outcomes

Primary

MeasureTime frame
Subject's assessment of the severity of hyperhidrosis using the HDS ScaleMonthly

Secondary

MeasureTime frame
Measurement of axillary sweat productionWeek 4, Week 8 and any re-injection visit

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026